Cargando…

Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models

PURPOSE: Taxanes are highly effective cytotoxic drugs for progressing breast cancer treatment. However, their poor solubility and high toxicity urge the development of innovative formulations of potential clinical relevance. MATERIALS AND METHODS: By using a simple and straightforward aggregation me...

Descripción completa

Detalles Bibliográficos
Autores principales: Foglietta, Federica, Spagnoli, Giulio C, Muraro, Manuele Giuseppe, Ballestri, Marco, Guerrini, Andrea, Ferroni, Claudia, Aluigi, Annalisa, Sotgiu, Giovanna, Varchi, Greta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122896/
https://www.ncbi.nlm.nih.gov/pubmed/30214193
http://dx.doi.org/10.2147/IJN.S159942
_version_ 1783352749647200256
author Foglietta, Federica
Spagnoli, Giulio C
Muraro, Manuele Giuseppe
Ballestri, Marco
Guerrini, Andrea
Ferroni, Claudia
Aluigi, Annalisa
Sotgiu, Giovanna
Varchi, Greta
author_facet Foglietta, Federica
Spagnoli, Giulio C
Muraro, Manuele Giuseppe
Ballestri, Marco
Guerrini, Andrea
Ferroni, Claudia
Aluigi, Annalisa
Sotgiu, Giovanna
Varchi, Greta
author_sort Foglietta, Federica
collection PubMed
description PURPOSE: Taxanes are highly effective cytotoxic drugs for progressing breast cancer treatment. However, their poor solubility and high toxicity urge the development of innovative formulations of potential clinical relevance. MATERIALS AND METHODS: By using a simple and straightforward aggregation method, we have generated paclitaxel (PTX) loaded in keratin nanoparticles (KER-NPs-PTX). Their activities were tested against human breast cancer MCF-7 and MDA MB 231 cell lines in conventional two-dimensional (2D) cultures and in a dynamic three-dimensional (3D) model with perfused bioreactor (p3D). Moreover, KER-NPs-PTX activity was compared to free PTX and to PTX loaded in albumin nanoparticles (HSA-NPs-PTX). Cell viability, induction of apoptosis, and gene expression analysis were used as readouts. RESULTS: In 2D cultures, KER-NPs-PTX was able to inhibit tumor cell viability and to induce apoptosis similarly to PTX and HSA-NPs-PTX. In the p3D model, a lower sensitivity of tumor cells to treatments was observed. Importantly, only KER-NPs-PTX was able to induce a statistically significant increase in apoptotic cell percentages following 24 h treatment for MCF-7 (16.7±4.0 early and 11.3±4.9 late apoptotic cells) and 48 h treatment for MDA MB 231 (21.3±11.2 early and 10.5±1.8 late apoptotic cells) cells. These effects were supported, at least for MCF-7 cells, by significant increases in the expression of proapoptotic BAX gene (5.8±0.5) 24 h after treatment and of cleaved caspase 3 (CC3) protein. CONCLUSION: KER-NPs-PTX, generated by a simple procedure, is characterized by high water solubility and enhanced PTX-loading ability, as compared to HSA-NPs-PTX. Most importantly, it appears to be able to exert effective anticancer activities on breast cancer cells cultured in 2D or in p3D models.
format Online
Article
Text
id pubmed-6122896
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61228962018-09-13 Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models Foglietta, Federica Spagnoli, Giulio C Muraro, Manuele Giuseppe Ballestri, Marco Guerrini, Andrea Ferroni, Claudia Aluigi, Annalisa Sotgiu, Giovanna Varchi, Greta Int J Nanomedicine Original Research PURPOSE: Taxanes are highly effective cytotoxic drugs for progressing breast cancer treatment. However, their poor solubility and high toxicity urge the development of innovative formulations of potential clinical relevance. MATERIALS AND METHODS: By using a simple and straightforward aggregation method, we have generated paclitaxel (PTX) loaded in keratin nanoparticles (KER-NPs-PTX). Their activities were tested against human breast cancer MCF-7 and MDA MB 231 cell lines in conventional two-dimensional (2D) cultures and in a dynamic three-dimensional (3D) model with perfused bioreactor (p3D). Moreover, KER-NPs-PTX activity was compared to free PTX and to PTX loaded in albumin nanoparticles (HSA-NPs-PTX). Cell viability, induction of apoptosis, and gene expression analysis were used as readouts. RESULTS: In 2D cultures, KER-NPs-PTX was able to inhibit tumor cell viability and to induce apoptosis similarly to PTX and HSA-NPs-PTX. In the p3D model, a lower sensitivity of tumor cells to treatments was observed. Importantly, only KER-NPs-PTX was able to induce a statistically significant increase in apoptotic cell percentages following 24 h treatment for MCF-7 (16.7±4.0 early and 11.3±4.9 late apoptotic cells) and 48 h treatment for MDA MB 231 (21.3±11.2 early and 10.5±1.8 late apoptotic cells) cells. These effects were supported, at least for MCF-7 cells, by significant increases in the expression of proapoptotic BAX gene (5.8±0.5) 24 h after treatment and of cleaved caspase 3 (CC3) protein. CONCLUSION: KER-NPs-PTX, generated by a simple procedure, is characterized by high water solubility and enhanced PTX-loading ability, as compared to HSA-NPs-PTX. Most importantly, it appears to be able to exert effective anticancer activities on breast cancer cells cultured in 2D or in p3D models. Dove Medical Press 2018-08-29 /pmc/articles/PMC6122896/ /pubmed/30214193 http://dx.doi.org/10.2147/IJN.S159942 Text en © 2018 Foglietta et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Foglietta, Federica
Spagnoli, Giulio C
Muraro, Manuele Giuseppe
Ballestri, Marco
Guerrini, Andrea
Ferroni, Claudia
Aluigi, Annalisa
Sotgiu, Giovanna
Varchi, Greta
Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title_full Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title_fullStr Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title_full_unstemmed Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title_short Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
title_sort anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122896/
https://www.ncbi.nlm.nih.gov/pubmed/30214193
http://dx.doi.org/10.2147/IJN.S159942
work_keys_str_mv AT fogliettafederica anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT spagnoligiulioc anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT muraromanuelegiuseppe anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT ballestrimarco anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT guerriniandrea anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT ferroniclaudia anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT aluigiannalisa anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT sotgiugiovanna anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels
AT varchigreta anticanceractivityofpaclitaxelloadedkeratinnanoparticlesintwodimensionalandperfusedthreedimensionalbreastcancermodels